Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
about
Recent advances in subtyping tumors of the central nervous system using molecular data.Advances in epigenetic glioblastoma therapy.Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cellsA Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples.Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas.Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ.Roles of zinc-fingers and homeoboxes 1 during the proliferation, migration, and invasion of glioblastoma cells.New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma.MicroRNA-141 is a tumor regulator and prognostic biomarker in human glioblastoma.5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cellsMultiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.Hexane fraction of Pluchea indica root extract inhibits proliferation and induces autophagy in human glioblastoma cells.Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.NF-κB Signalling in Glioblastoma.Efficient gene silencing in brain tumors with hydrophobically modified siRNAs.Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.Silencing LDHA inhibits proliferation, induces apoptosis and increases chemosensitivity to temozolomide in glioma cells.Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.The developmental origin of brain tumours: a cellular and molecular framework.Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.An orthotopic glioblastoma animal model suitable for high-throughput screeningsImmune Checkpoints and Innovative Therapies in GlioblastomaIntegrating in vitro experiments with in silico approaches for Glioblastoma invasion: the role of cell-to-cell adhesion heterogeneity
P2860
Q31145092-4ADF09D5-70B0-4C72-819F-B3B3634FF9DCQ33567030-DF65D56C-4622-41F3-B7AC-2F5488361F10Q33568348-CFF3D09A-6D23-4412-B719-3782A83FC228Q33798642-A07206B4-819A-4353-A295-6514EC61DC1EQ36259923-15074F7D-42B9-4134-8A23-7B92615F6C9FQ37573471-028F34DA-413E-42A8-9C48-302BD0557FE9Q37699166-7E0EEFEC-30BE-44C7-96DB-FD2242476310Q38709896-67FA8866-634F-418B-AB18-5E7886C475ACQ40046161-B2F08D6A-D216-44B3-BE0D-9C34610741C4Q41098467-768D5CF4-89A9-4517-BA03-64BC1D7ED36FQ41298452-53E63620-C136-4699-BEE6-49043EF4ED8DQ41744145-FC0795C9-8CEC-4619-9275-3245B80BD991Q45869675-715A2FE1-B1C0-445A-A13C-D152925CE65CQ47161585-E94E9CF3-FE8E-4B3E-AFB3-046C129E97FBQ47592896-A02DDE11-97DF-48B3-9965-4762990959B8Q52091959-2AF9A792-0AE9-4FB2-927B-8E36334B3D34Q52321920-6432363A-808B-4896-B116-59D6DB86F414Q52590668-85B40999-3D33-4ECA-B68B-BF9A0B92846FQ52649731-4A4E4E14-8EB1-4236-BA17-8F3191AEBCBAQ55171954-6CF2CAD8-130F-4F46-B8AE-180F122E7038Q55399267-85E6F960-4397-4AC4-A79A-733BA9DD1EBBQ55425154-4DB12EF4-8AFC-4C02-AC63-906A555C1A76Q57291651-3CC146F7-7674-4FF0-A45D-DF4367D0BD1AQ58573409-CF89BC20-884F-45AA-BF2E-879C0F35CE28Q58577644-B30B6464-B0E3-4DBC-8726-D3EF369D4F68
P2860
Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@ast
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@en
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@nl
type
label
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@ast
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@en
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@nl
prefLabel
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@ast
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@en
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@nl
P2093
P2860
P356
P1476
Current Challenges in Glioblas ...... to Predict Disease Recurrence
@en
P2093
Andrea Sottoriva
Ben Powell
Hayley P Ellis
Inmaculada Spiteri
Kathreena M Kurian
Mark Greenslade
P2860
P356
10.3389/FONC.2015.00251
P407
P577
2015-01-01T00:00:00Z